· 2/20/2014
Takeda Pharmaceutical Co. v. Zydus Pharmaceuticals USA, Inc.
Citations
- 743 F.3d 1359
- 109 U.S.P.Q. 2d (BNA) 1825
- 2014 U.S. App. LEXIS 3072
- 2014 WL 642714
How courts have described this case
Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.
- holding that a patent was adequately enabled “because the patent identifies laser diffraction as a viable measurement technique, and there is no dispute that a skilled artisan would know how to use laser diffraction to measure particle diameter”
- concluding term “fine granules having an average particle diameter of 400 μm or less” meant “fine granules having an average particle diameter of precisely 400 μm or less”
- explaining that the “mere possibility of different results” is insufficient for indefiniteness
- explaining that the “mere possibility of different results” is insufficient for indefiniteness
- explaining that the “mere possibility of different results” is insufficient for indefiniteness
- refusing to read in a limitation because the specification indicated that the inventor knew how to claim such a limitation “when [he] so desired”
Source: CourtListener parenthetical corpus (CC0).
Judges: Prost, Plager, Chen
Read full opinion on CourtListenerSourced from CourtListener / Free Law Project (CC0).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.